Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2020

25.07.2020 | Commentary

Bourgeoning Scientific Research in Down Syndrome

verfasst von: Dusan Bogunovic

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Excerpt

The earliest evidence of existence of individuals with Down syndrome (DS) dates to ancient art in Mesoamerica. Furthermore, analysis of bone structure from graves in France, California, and Ireland suggests that individuals with DS were part of our societies for millennia. In more modern medical terms, DS was described in the mid-1800s by scientists in France and England [1, 2]. A century later, in 1959, the genetic underpinning was described leading to now the synonymous term trisomy 21 (although the genetics of DS can be substantially more complex) [3]. Either way, tremendous progress has been made over the last half a century in the medical treatment of individuals with DS. The life expectancy for individuals with DS went from about 30 years in the 1980s to about 60 years in 2020 [4]. But there is much more we can, should, and actually are doing to understand physiology of individuals with DS. In this issue of JoCI, a review article and a research article are dedicated to immunology in individuals with DS. …
Literatur
1.
Zurück zum Zitat Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995;33(1):54–6.PubMed Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995;33(1):54–6.PubMed
2.
Zurück zum Zitat Evans-Martin FF. Down syndrome. Genes & disease. New York: Chelsea House; 2009. 144 p Evans-Martin FF. Down syndrome. Genes & disease. New York: Chelsea House; 2009. 144 p
3.
Zurück zum Zitat Lejeune J, Gauthier M, Turpin R. Human chromosomes in tissue cultures. C R Hebd Seances Acad Sci. 1959;248(4):602–3.PubMed Lejeune J, Gauthier M, Turpin R. Human chromosomes in tissue cultures. C R Hebd Seances Acad Sci. 1959;248(4):602–3.PubMed
4.
5.
Zurück zum Zitat Verstegen RHJ, Kusters MAA. Inborn errors of adaptive immunity in Down syndrome. J Clin Immunol. 2020. Verstegen RHJ, Kusters MAA. Inborn errors of adaptive immunity in Down syndrome. J Clin Immunol. 2020.
6.
Zurück zum Zitat Kong X-F, Worley L, Rinchai D, Bondet V, Jithesh PV, Goulet M, et al. Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome. J Clin Immunol. 2020. Kong X-F, Worley L, Rinchai D, Bondet V, Jithesh PV, Goulet M, et al. Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome. J Clin Immunol. 2020.
7.
Zurück zum Zitat Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, et al. Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome. Cell Rep. 2019;29(7):1893–908 e4.CrossRef Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, et al. Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome. Cell Rep. 2019;29(7):1893–908 e4.CrossRef
8.
Zurück zum Zitat Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, et al. Trisomy 21 consistently activates the interferon response. Elife. 2016;5. Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, et al. Trisomy 21 consistently activates the interferon response. Elife. 2016;5.
9.
Zurück zum Zitat Altman JB, Taft J, Wedeking T, Gruber CN, Holtmannspötter M, Piehler J, et al. Type I IFN is siloed in endosomes. [published online ahead of print, 2020 Jul 14]. Proc Natl Acad Sci U S A. 2020;201921324. Altman JB, Taft J, Wedeking T, Gruber CN, Holtmannspötter M, Piehler J, et al. Type I IFN is siloed in endosomes.  [published online ahead of print, 2020 Jul 14]. Proc Natl Acad Sci U S A. 2020;201921324.
10.
Zurück zum Zitat Malle L, et al. COVID-19 hospitalization is more frequent and severe in Down syndrome. medRxiv. 2020:2020.05.26.20112748. Malle L, et al. COVID-19 hospitalization is more frequent and severe in Down syndrome. medRxiv. 2020:2020.05.26.20112748.
Metadaten
Titel
Bourgeoning Scientific Research in Down Syndrome
verfasst von
Dusan Bogunovic
Publikationsdatum
25.07.2020
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2020
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-020-00837-z

Weitere Artikel der Ausgabe 6/2020

Journal of Clinical Immunology 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.